Vivani Medical, Inc. (NASDAQ:VANI – Get Rating) was down 2.5% on Tuesday . The stock traded as low as $0.86 and last traded at $0.91. Approximately 119,948 shares changed hands during mid-day trading, an increase of 4% from the average daily volume of 115,268 shares. The stock had previously closed at $0.93.
Analyst Upgrades and Downgrades
Separately, ThinkEquity started coverage on Vivani Medical in a report on Monday, December 5th. They issued a "buy" rating and a $7.00 price target for the company.
Get
Vivani Medical alerts:
Vivani Medical Stock Down 2.5 %
The firm has a fifty day moving average price of $1.52.
Institutional Investors Weigh In On Vivani Medical
A number of institutional investors and hedge funds have recently modified their holdings of the company. State Street Corp acquired a new stake in shares of Vivani Medical during the third quarter worth about $63,000. Vanguard Group Inc. acquired a new stake in shares of Vivani Medical during the third quarter worth about $682,000. Prelude Capital Management LLC acquired a new stake in shares of Vivani Medical during the third quarter worth about $25,000. BlackRock Inc. acquired a new stake in shares of Vivani Medical during the third quarter worth about $734,000. Finally, Commonwealth Equity Services LLC acquired a new stake in shares of Vivani Medical during the third quarter worth about $822,000.
Vivani Medical Company Profile
(Get Rating)
Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.
Featured Stories
- Get a free copy of the StockNews.com research report on Vivani Medical (VANI)
- 3 Industrial Stocks to Help Build Your 2023 Watchlist
- The Institutions Choose CarMax Over Carvana, Should You?
- Heatmap in Trading: How to Learn What Market Depth Hides
- Micron Technology Sees Chip Recovery by the End of 2023
- Three Healthcare Penny Stocks to Watch In The New Year
Receive News & Ratings for Vivani Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivani Medical and related companies with MarketBeat.com's FREE daily email newsletter.
Vivani Medical, Inc. (NASDAQ:VANI – Get Rating) was down 2.5% on Tuesday . The stock traded as low as $0.86 and last traded at $0.91. Approximately 119,948 shares changed hands during mid-day trading, an increase of 4% from the average daily volume of 115,268 shares. The stock had previously closed at $0.93.
維萬尼醫療公司 (NASDAQ: 凡尼 — 獲取評級) 是下降 2.5% 在星期二.該股票的交易價格低至 0.86 美元,最後交易價格為 0.91 美元。大約 119,948 股股票在日間交易期間轉手,較每日平均成交量 115,268 股增加 4%。該股票之前已收盤 0.93 美元。
Analyst Upgrades and Downgrades
Separately, ThinkEquity started coverage on Vivani Medical in a report on Monday, December 5th. They issued a "buy" rating and a $7.00 price target for the company.
另外,思想開始覆蓋維瓦尼醫療在週一的報告中,12 月 5 日。他們為該公司發布了「買入」評級和 7.00 美元的目標價格。
Get
Vivani Medical
alerts:
Vivani Medical Stock Down 2.5 %
The firm has a fifty day moving average price of $1.52.
Institutional Investors Weigh In On Vivani Medical
A number of institutional investors and hedge funds have recently modified their holdings of the company. State Street Corp acquired a new stake in shares of Vivani Medical during the third quarter worth about $63,000. Vanguard Group Inc. acquired a new stake in shares of Vivani Medical during the third quarter worth about $682,000. Prelude Capital Management LLC acquired a new stake in shares of Vivani Medical during the third quarter worth about $25,000. BlackRock Inc. acquired a new stake in shares of Vivani Medical during the third quarter worth about $734,000. Finally, Commonwealth Equity Services LLC acquired a new stake in shares of Vivani Medical during the third quarter worth about $822,000.
一些機構投資者和對沖基金最近修改了他們對該公司的持有。國街公司在第三季度收購了維萬尼醫療股份的新股份,價值約 63,000 美元。領航集團股份有限公司在第三季度收購了維萬尼醫療股份的新股份,價值約為 682,000 美元。前奏資本管理有限責任公司收購維萬尼醫療的股份新股份在第三季度價值約 $25,000.貝萊德在第三季度收購了維萬尼醫療股份的新股份,價值約 734,000 美元。最後,英聯邦股權服務有限責任公司在第三季度收購了維萬尼醫療股份的新股份,價值約為 822,000 美元。
Vivani Medical Company Profile
Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.
Vivani Medical, Inc 是一家臨床階段公司,開發各種植入物,用於治療未滿足的高度醫療需求的慢性疾病。它致力於開發微型藥物植入物的產品組合,以提供最小波動的藥物特徵;以及可植入的視覺假肢裝置,為盲人提供有用的人工視覺。
Featured Stories
- Get a free copy of the StockNews.com research report on Vivani Medical (VANI)
- 3 Industrial Stocks to Help Build Your 2023 Watchlist
- The Institutions Choose CarMax Over Carvana, Should You?
- Heatmap in Trading: How to Learn What Market Depth Hides
- Micron Technology Sees Chip Recovery by the End of 2023
- Three Healthcare Penny Stocks to Watch In The New Year
- 免費獲取有關薇萬尼醫療(VANI)的研究報告
- 3 種工業股票可幫助建立您的 2023 觀察列表
- 機構選擇 CarMax 而不是卡瓦娜,你應該嗎?
- 交易中的熱圖:如何了解市場深度隱藏了什麼
- 美光技術將在 2023 年底前恢復芯片
- 三個醫療保健便士股在新的一年要關注
Receive News & Ratings for Vivani Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivani Medical and related companies with MarketBeat.com's FREE daily email newsletter.
接收 Vivani 醫療日報的新聞和評分 -在下面輸入您的電子郵件地址,以通過 MarketBeat.com 的免費每日電子郵件通訊接收 Vivani Medical 及相關公司的最新新聞和分析師評級的簡要每日摘要。